SmithKline Beecham Pharma Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1997) 138 F.T.R. 310 (TD)
Linked as:
Extract
SmithKline Beecham Pharma Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1997) 138 F.T.R. 310 (TD)
No longer available (Autolink)
See the full content of this document
This document cites
- Apotex Inc. v. Canada (Minister of National Health and Welfare) et al., (1997) 219 N.R. 151 (FCA)
- Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1995) 106 F.T.R. 294 (TD)
- Glaxo Wellcome Inc. et al. v. Canada (Minister of National Health and Welfare) and Apotex Inc., (1997) 134 F.T.R. 220 (TD)
- Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1997) 132 F.T.R. 60 (TD)
